Table 2.

Classic lipid profile at D1 and D30 by groups of lipid-lowering therapies

Parameters	Simvastatin plus ezetimibe N = 50	Rosuvastatin monotherapy N = 51	P value
At baseline (D1)
Cholesterol, mg/dL	188 (174–223)	199 (168–227)	0.83
LDL-C, mg/dL	127 (113–153)	129 (107–150)	0.73
HDL-C, mg/dL	40 (31–46)	36 (31–45)	0.32
Triglycerides, mg/dL	140 (98–214)	157 (98–232)	0.42
Non-HDL-C, mg/dL	154 (137–193)	160 (139–193)	0.92
After 30 days (D30)
Cholesterol, mg/dL	121 (98–141)	119 (105–141)	0.53
LDL-C, mg/dL	58 (43–82)	61 (50–82)	0.39
HDL-C, mg/dL	37 (31–44)	37 (32–40)	0.93
Triglycerides, mg/dL	133 (107–187)	140 (100–178)	0.93
Non-HDL-C, mg/dL	78 (65–112)	83 (70–105)	0.66

Values are medians (IQRs). Blood samples were collected on the first (D1) and 30 (D30) days after myocardial infarction. Variables were compared by the Mann–Whitney U test